EXPRESSION OF THE RET PROTOONCOGENE PRODUCT IN HUMAN NORMAL AND NEOPLASTIC TISSUES OF NEURAL CREST ORIGIN

被引:118
作者
NAKAMURA, T
ISHIZAKA, Y
NAGAO, M
HARA, M
ISHIKAWA, T
机构
[1] UNIV TOKYO,FAC MED,DEPT PATHOL,TOKYO 113,JAPAN
[2] NATL CANC CTR,RES INST,DIV CARCINOGENESIS,TOKYO 104,JAPAN
[3] TORANOMON GEN HOSP,DEPT PATHOL,TOKYO,JAPAN
关键词
PROTO-RET; NEURAL CREST; IMMUNOHISTOCHEMISTRY; DIFFERENTIATION;
D O I
10.1002/path.1711720305
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The histological localization of the ret proto-oncogene (proto-ret) product was examined in neural crest-derived and neuronal tissues together with their neoplastic counterparts by immunohistochemistry using a polyclonal antibody. Schwann cells, neurons, sympathetic ganglia, and cells of the adrenal medulla were positive for the proto-ret product, whereas melanocytes were negative. Positive results were obtained from neural crest-derived tumours such as schwannoma (69 per cent, 11/16), neurofibroma (59 per cent, 13/22), neuroblastoma (80 per cent, 4/5), phaeochromocytoma (100 per cent, 3/3) and medullary thyroid carcinoma (100 per cent, 3/3). The antibody reacted with all of the 22 astrocytomas examined. With negative proto-ret expression in melanocytic tumours, proto-ret expression was considered to correlate with the differentiation of some lineages of neural crest-derived cells.
引用
收藏
页码:255 / 260
页数:6
相关论文
共 21 条
  • [1] PTC IS A NOVEL REARRANGED FORM OF THE RET PROTO-ONCOGENE AND IS FREQUENTLY DETECTED INVIVO IN HUMAN THYROID PAPILLARY CARCINOMAS
    GRIECO, M
    SANTORO, M
    BERLINGIERI, MT
    MELILLO, RM
    DONGHI, R
    BONGARZONE, I
    PIEROTTI, MA
    DELLAPORTA, G
    FUSCO, A
    VECCHIO, G
    [J]. CELL, 1990, 60 (04) : 557 - 563
  • [2] USE OF AVIDIN-BIOTIN-PEROXIDASE COMPLEX (ABC) IN IMMUNOPEROXIDASE TECHNIQUES - A COMPARISON BETWEEN ABC AND UNLABELED ANTIBODY (PAP) PROCEDURES
    HSU, SM
    RAINE, L
    FANGER, H
    [J]. JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1981, 29 (04) : 577 - 580
  • [3] IKEDA I, 1990, ONCOGENE, V5, P1291
  • [4] ISHIZAKA Y, 1989, ONCOGENE, V4, P1519
  • [5] ISHIZAKA Y, 1992, ONCOGENE, V7, P1441
  • [6] CDNA CLONING AND CHARACTERIZATION OF RET ACTIVATED IN A HUMAN PAPILLARY THYROID-CARCINOMA CELL-LINE
    ISHIZAKA, Y
    USHIJIMA, T
    SUGIMURA, T
    NAGAO, M
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 168 (02) : 402 - 408
  • [7] PRESENCE OF ABERRANT TRANSCRIPTS OF RET PROTO-ONCOGENE IN A HUMAN PAPILLARY THYROID-CARCINOMA CELL-LINE
    ISHIZAKA, Y
    ITOH, F
    TAHIRA, T
    IKEDA, I
    OGURA, T
    SUGIMURA, T
    NAGAO, M
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1989, 80 (12): : 1149 - 1152
  • [8] ITO F, 1989, TUMOR RES, V24, P1
  • [9] A LINKED GENETIC-MARKER FOR MULTIPLE ENDOCRINE NEOPLASIA TYPE-2A ON CHROMOSOME-10
    MATHEW, CGP
    CHIN, KS
    EASTON, DF
    THORPE, K
    CARTER, C
    LIOU, GI
    FONG, SL
    BRIDGES, CDB
    HAAK, H
    KRUSEMAN, ACN
    SCHIFTER, S
    HANSEN, HH
    TELENIUS, H
    TELENIUSBERG, M
    PONDER, BAJ
    [J]. NATURE, 1987, 328 (6130) : 527 - 528
  • [10] GERM-LINE MUTATIONS OF THE RET PROTOONCOGENE IN MULTIPLE ENDOCRINE NEOPLASIA TYPE-2A
    MULLIGAN, LM
    KWOK, JBJ
    HEALEY, CS
    ELSDON, MJ
    ENG, C
    GARDNER, E
    LOVE, DR
    MOLE, SE
    MOORE, JK
    PAPI, L
    PONDER, MA
    TELENIUS, H
    TUNNACLIFFE, A
    PONDER, BAJ
    [J]. NATURE, 1993, 363 (6428) : 458 - 460